Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs.

Synthetic approaches to the 2012 new drugs.

Synthetic approaches to the 2013 new drugs.

Approaches to the chemical synthesis of the chlorosulfolipids.

Low-molecular-weight heparin and other new antithrombotic drugs.

Antithrombotic drugs: part II.

New approaches to the synthesis of antiviral nucleosides.

Pharmacogenetics and oral antithrombotic drugs.

Chemical approaches to cell reprogramming.

Synthesis of thiolated glycosaminoglycans and grafting to solid surfaces.

Factor concentrates for perioperative bleeding: old drugs with new approaches.

New methods for chemical protein synthesis.

Approaches to measuring entanglement in chemical magnetometers.

Antithrombotic activity of glycosaminoglycans of mammalian origin. In vivo experiments in the rabbit.

Proteomic signatures of antiplatelet drugs: new approaches to exploring drug effects.

[11C]octopamine synthesis using [11C]cyanide: chemical and enzymatic approaches for the [11C]cyanohydrin synthesis.

New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.

New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings.

Chemical delivery systems and soft drugs: Retrometabolic approaches of drug design.

Antithrombotic therapy: new areas to understand efficacy and bleeding.

IIIa antagonists as antithrombotic drugs.

New approaches to radiation protection.

New approaches to TB vaccination.

New approaches to cardiovascular surgery.

Novel approaches to the development of anti-sepsis drugs.

Suggest Documents

Synthetic approaches to the 2012 new drugs.

Synthetic approaches to the 2013 new drugs.

Approaches to the chemical synthesis of the chlorosulfolipids.

Low-molecular-weight heparin and other new antithrombotic drugs.

Antithrombotic drugs: part II.

New approaches to the synthesis of antiviral nucleosides.

Pharmacogenetics and oral antithrombotic drugs.

Chemical approaches to cell reprogramming.

Synthesis of thiolated glycosaminoglycans and grafting to solid surfaces.

Factor concentrates for perioperative bleeding: old drugs with new approaches.

New methods for chemical protein synthesis.

Approaches to measuring entanglement in chemical magnetometers.

Antithrombotic activity of glycosaminoglycans of mammalian origin. In vivo experiments in the rabbit.

Proteomic signatures of antiplatelet drugs: new approaches to exploring drug effects.

[11C]octopamine synthesis using [11C]cyanide: chemical and enzymatic approaches for the [11C]cyanohydrin synthesis.

New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.

New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings.

Chemical delivery systems and soft drugs: Retrometabolic approaches of drug design.

Antithrombotic therapy: new areas to understand efficacy and bleeding.

IIIa antagonists as antithrombotic drugs.

New approaches to radiation protection.

New approaches to TB vaccination.

New approaches to cardiovascular surgery.

Novel approaches to the development of anti-sepsis drugs.

Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs.

Recommend Documents

Follow Us